Increased mitochondrial DNA copy-number in CEM cells resistant to delayed toxicity of 2′,3′-dideoxycytidine
-
Add time:08/03/2019 Source:sciencedirect.com
The nucleoside analog 2′,3′-dideoxycytidine (ddC) has been used for treatment of human immunodeficiency virus (HIV) infections. ddC causes delayed toxicity when cells are exposed to the drug at low concentration for prolonged periods of time. The delayed toxicity is due to inhibition of mitochondrial DNA (mtDNA) replication, which results in mtDNA depletion and mitochondrial dysfunction. In the present study we have cultured CEM T-lymphoblast cells in the presence of low concentrations of ddC to generate two cell lines resistant to the delayed toxicity of the drug. Both cell lines were resistant to mtDNA depletion by ddC. The mechanism of ddC resistance was investigated and we showed that the resistant cells had decreased mRNA expression of the nucleoside kinases deoxycytidine kinase and thymidine kinase 2. We also studied the mitochondrial DNA in the cells and showed that the ddC-resistant cells had structurally intact mtDNA but 1.5–2-fold increased mtDNA copy-number as well as increased levels of the mitochondrial transcription factor A (Tfam). Our study suggests that cells may increase their level of mtDNA to counteract mtDNA depletion induced by ddC, while keeping pronounced antiviral activity of the drug.
We also recommend Trading Suppliers and Manufacturers of 2',3'-dideoxycytidine monophosphate (cas 104086-75-1). Pls Click Website Link as below: cas 104086-75-1 suppliers
Prev:Synthesis and biological evaluation of dinucleoside methylphosphonates of 3′-azido-3′-deoxythymidine and 2′, 3′-dideoxycytidine
Next:Inhibition of duck hepatitis B virus replication by 2′,3′-dideoxycytidine) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- 2′, 3′-Dideoxycytidine represses thymidine kinases 1 and 2 expression in T-lymphoid cells08/09/2019
- The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell species08/08/2019
- Effect of 2′,3′-dideoxycytidine on oxidative phosphorylation in the PC 12 cell, a neuronal model08/07/2019
- Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivity08/06/2019
- Pharmacodynamics of 2′,3′-dideoxycytidine: An inhibitor of human immunodeficiency virus08/05/2019
- Inhibition of duck hepatitis B virus replication by 2′,3′-dideoxycytidine08/04/2019
- Synthesis and biological evaluation of dinucleoside methylphosphonates of 3′-azido-3′-deoxythymidine and 2′, 3′-dideoxycytidine08/02/2019
- Effects of 2′,3′-dideoxycytidine and 2′,3′-dideoxycytidine 5′-triphosphate on phospholipid metabolism in permeabilized rat hepatocytes08/01/2019
